HTATIP2 and melanoma: HTATIP2 frequently exhibits downregulation in various tumor cells, such as breast cancer, colon cancer, pancreatic cancer, melanoma, glioblastoma, neuroblastoma, SCLC, and HCC cells[14, 17-22].